During the past decade, Acibadem Adana Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Acibadem Adana Hospital" #1 sponsor was "BeiGene" with 3 trials, followed by "Global Blood Therapeutics" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Acibadem Adana Hospital" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Acibadem Adana Hospital" are "Hemophilia A" (3 trials), "Hemophilia B" (3 trials), "Non-small Cell Lung Cancer" (3 trials), "Sickle Cell Disease" (3 trials) and "Vaso-occlusive Crisis" (2 trials). Many other conditions were trialed in "Acibadem Adana Hospital" in a lesser frequency.

Most popular intervention types in "Acibadem Adana Hospital" are "Drug" (23 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cisplatin" (4 trials), "Capecitabine" (3 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Acibadem Adana Hospital" are 24 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Acibadem Adana Hospital". undefined are not yet recruiting, 15 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Acibadem Adana Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Acibadem Adana Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".